INmune Bio (INMB) Stock Price, Quote, News & History

SPY772.04+0.09%QQQ745.40+0.12%BTC/USD84,543.36+0.13%DIA517.72+0.04%GLD393.05−0.09%TLT79.38+0.08%

INmune Bio Inc (INMB) Stock Price, Quote, News & History

INMBNASDAQ

Trade with Public

$2.03

0.031.5%

At close: Sep 25, 5:00 PM EST

$2.01

-0.02-0.99%

After Hours: Sep 25, 6:29 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$2.01

$2.03

Volume / Avg.

196.17K / 727.18K

Day Range

$1.96 - $2.04

52 Wk Range

1.09 - 2.60

Market Cap

$55.79M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

9.08%

Days to Cover

7.78

Recent INmune Bio Inc News

Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

INmune Bio Rebounds Sharply During After Hours Trading: What's Driving the Surge?

Following the announcement of TNF inhibitor, INmune Bio Inc. stock surged by 24.72% in after-hours trading on Friday.

Mohd Haider

'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday

Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge.

Vishaal Sanjay

'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday

Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge.

Vishaal Sanjay

This Textron Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-14.96M

Investing Cash Flow (TTM)

-766.00K

Financing Cash Flow (TTM)

816.00K

Free Cash Flow (TTM)

-15.73M

Capital Expenditure (TTM)

-766.00K

Net Change in Cash (TTM)

-14.91M

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$39.20M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

2.74

Earnings Yield % (TTM)

-30.85%

Earnings Yield % (FWD)

-21.39%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.73

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$18.41M

Debt to Equity

0.07

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$2.01

$2.03

Volume / Avg.

196.17K / 727.18K

Day Range

$1.96 - $2.04

52 Wk Range

1.09 - 2.60

Market Cap

$55.79M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

9.08%

Days to Cover

7.78

About

Sector

Health Care

Industry

Biotechnology

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy INmune Bio (INMB) stock?

You can purchase shares of INmune Bio (NASDAQ:INMB) through any online brokerage.

View our list of the best stock brokerages

Who are INmune Bio (INMB) competitors?

Other companies in INmune Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

What is the forecast, or price target, for INmune Bio (INMB) stock?

INmune Bio has a consensus price target of $9.93.

What is the current price for INmune Bio (INMB)?

The stock price for INmune Bio (NASDAQ: INMB) is $2.01 last updated September 25, 2026 at 6:29 PM EDT.

Does INmune Bio (INMB) pay a dividend?

There are no upcoming dividends for INmune Bio.

When is INmune Bio (NASDAQ:INMB) reporting earnings?

INmune Bio does not have any upcoming earnings scheduled.

Is INmune Bio (INMB) going to split?

There is no upcoming split for INmune Bio.

What sector and industry does INmune Bio (INMB) operate in?

INmune Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

INmune Bio Inc (INMB) Stock Price, Quote, News & History

INmune Bio (INMB) Stock Price, Quote, News & History | Benzinga

Key Statistics

Recent INmune Bio Inc News

Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

INmune Bio Rebounds Sharply During After Hours Trading: What's Driving the Surge?

'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday

'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday

This Textron Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Financials

Cash Flows

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

FAQ

How do I buy INmune Bio (INMB) stock?

Who are INmune Bio (INMB) competitors?

What is the forecast, or price target, for INmune Bio (INMB) stock?

What is the current price for INmune Bio (INMB)?

Does INmune Bio (INMB) pay a dividend?

When is INmune Bio (NASDAQ:INMB) reporting earnings?

Is INmune Bio (INMB) going to split?

What sector and industry does INmune Bio (INMB) operate in?